BioSyent Statistics
Total Valuation
BioSyent has a market cap or net worth of 98.95 million. The enterprise value is 82.72 million.
| Market Cap | 98.95M |
| Enterprise Value | 82.72M |
Important Dates
The last earnings date was Thursday, November 20, 2025.
| Earnings Date | Nov 20, 2025 |
| Ex-Dividend Date | Nov 28, 2025 |
Share Statistics
| Current Share Class | 11.26M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -2.73% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 13.96% |
| Owned by Institutions (%) | 19.49% |
| Float | 8.60M |
Valuation Ratios
The trailing PE ratio is 15.96.
| PE Ratio | 15.96 |
| Forward PE | n/a |
| PS Ratio | 3.27 |
| PB Ratio | 3.45 |
| P/TBV Ratio | 3.93 |
| P/FCF Ratio | 17.01 |
| P/OCF Ratio | 16.93 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 9.47, with an EV/FCF ratio of 14.22.
| EV / Earnings | 13.35 |
| EV / Sales | 2.72 |
| EV / EBITDA | 9.47 |
| EV / EBIT | 10.06 |
| EV / FCF | 14.22 |
Financial Position
The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.02.
| Current Ratio | 5.06 |
| Quick Ratio | 4.18 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.11 |
| Interest Coverage | 219.94 |
Financial Efficiency
Return on equity (ROE) is 22.35% and return on invested capital (ROIC) is 17.99%.
| Return on Equity (ROE) | 22.35% |
| Return on Assets (ROA) | 15.28% |
| Return on Invested Capital (ROIC) | 17.99% |
| Return on Capital Employed (ROCE) | 28.03% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.90 |
| Inventory Turnover | 1.64 |
Taxes
In the past 12 months, BioSyent has paid 2.28 million in taxes.
| Income Tax | 2.28M |
| Effective Tax Rate | 26.85% |
Stock Price Statistics
The stock price has increased by +10.44% in the last 52 weeks. The beta is 0.39, so BioSyent's price volatility has been lower than the market average.
| Beta (5Y) | 0.39 |
| 52-Week Price Change | +10.44% |
| 50-Day Moving Average | 8.14 |
| 200-Day Moving Average | 8.08 |
| Relative Strength Index (RSI) | 68.15 |
| Average Volume (20 Days) | 1,997 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioSyent had revenue of 30.28 million and earned 6.20 million in profits. Earnings per share was 0.54.
| Revenue | 30.28M |
| Gross Profit | 23.46M |
| Operating Income | 8.19M |
| Pretax Income | 8.47M |
| Net Income | 6.20M |
| EBITDA | 8.60M |
| EBIT | 8.19M |
| Earnings Per Share (EPS) | 0.54 |
Balance Sheet
The company has 16.80 million in cash and 641,025 in debt, giving a net cash position of 16.16 million.
| Cash & Cash Equivalents | 16.80M |
| Total Debt | 641,025 |
| Net Cash | 16.16M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 28.65M |
| Book Value Per Share | 2.54 |
| Working Capital | 20.72M |
Cash Flow
In the last 12 months, operating cash flow was 5.84 million and capital expenditures -24,924, giving a free cash flow of 5.82 million.
| Operating Cash Flow | 5.84M |
| Capital Expenditures | -24,924 |
| Free Cash Flow | 5.82M |
| FCF Per Share | n/a |
Margins
Gross margin is 77.46%, with operating and profit margins of 27.04% and 20.47%.
| Gross Margin | 77.46% |
| Operating Margin | 27.04% |
| Pretax Margin | 27.98% |
| Profit Margin | 20.47% |
| EBITDA Margin | 28.40% |
| EBIT Margin | 27.04% |
| FCF Margin | 19.22% |
Dividends & Yields
This stock pays an annual dividend of 0.14, which amounts to a dividend yield of 1.63%.
| Dividend Per Share | 0.14 |
| Dividend Yield | 1.63% |
| Dividend Growth (YoY) | 9.62% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 25.50% |
| Buyback Yield | 2.73% |
| Shareholder Yield | 4.36% |
| Earnings Yield | 6.26% |
| FCF Yield | 5.88% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioSyent has an Altman Z-Score of 13.13 and a Piotroski F-Score of 5.
| Altman Z-Score | 13.13 |
| Piotroski F-Score | 5 |